Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
E G Levin, Yaniv Lustig, Carmit Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 1086

Showing 1-25 of 1086 citing articles:

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Wilfredo F. García-Beltrán, Kerri St. Denis, Angelique Hœlzemer, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 457-466.e4
Open Access | Times Cited: 1032
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 1011
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Victoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 13, pp. 1207-1220
Open Access | Times Cited: 637
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 573
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Roanne Keeton, Marius B. Tincho, Amkele Ngomti, et al.
Nature (2022) Vol. 603, Iss. 7901, pp. 488-492
Open Access | Times Cited: 548
Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 422
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 414
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
Gili Regev‐Yochay, Tal Gonen, Mayan Gilboa, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 14, pp. 1377-1380
Open Access | Times Cited: 404
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 23, pp. 2201-2212
Open Access | Times Cited: 387
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Katharina Röltgen, Sandra C. A. Nielsen, Oscar Silva, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1025-1040.e14
Open Access | Times Cited: 383
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 486-489
Open Access | Times Cited: 354
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 311
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
Edson Duarte Moreira, Nicholas Kitchin, Xia Xu, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 20, pp. 1910-1921
Open Access | Times Cited: 311
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
Jeffrey V. Lazarus, Katarzyna Wyka, Trenton M. White, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 366-375
Open Access | Times Cited: 293
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
Timothy A. Bates, Savannah K. McBride, Hans C. Leier, et al.
Science Immunology (2022) Vol. 7, Iss. 68
Open Access | Times Cited: 284
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
Peter Nordström, Marcel Ballin, Anna Nordström
The Lancet (2022) Vol. 399, Iss. 10327, pp. 814-823
Open Access | Times Cited: 281
Modeling transmission of SARS-CoV-2 Omicron in China
Jun Cai, Xiaowei Deng, Juan Yang, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1468-1475
Open Access | Times Cited: 254
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 238
The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good
Kevin Bardosh, Alexandre de Figueiredo, Rachel Gur‐Arie, et al.
BMJ Global Health (2022) Vol. 7, Iss. 5, pp. e008684-e008684
Open Access | Times Cited: 236
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Jia Wei, Koen B. Pouwels, Nicole Stoesser, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1072-1082
Open Access | Times Cited: 221
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 220
BNT162b2 Vaccine Booster and Mortality Due to Covid-19
Ronen Arbel, Ariel Hammerman, Ruslan Sergienko, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 26, pp. 2413-2420
Open Access | Times Cited: 217
BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
Gisella Guerrera, Mario Picozza, Silvia D’Orso, et al.
Science Immunology (2021) Vol. 6, Iss. 66
Open Access | Times Cited: 207
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
Alejandro Jara, Eduardo A. Undurraga, José R. Zubizarreta, et al.
The Lancet Global Health (2022) Vol. 10, Iss. 6, pp. e798-e806
Open Access | Times Cited: 192
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
Rishi R. Goel, Mark M. Painter, Kendall A. Lundgreen, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1875-1887.e8
Open Access | Times Cited: 186
Page 1 - Next Page

Scroll to top